$CGTX Income Statement | Understand Stock

$CGTX

$0.76 +$0.06 (9.24%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating Expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense):
Grant income
Change in the fair value of the derivative liability
Change in the fair value of the Simple Agreements for Future Equity
Other income, net
Gain on debt extinguishment
Interest expense
Loss on currency translation from liquidation of subsidiary
Total other income, net

Net loss
Cumulative preferred stock dividends
Net loss attributable to common stockholders
Unrealized gain (loss) on foreign currency translation
Foreign currency translation adjustment, including reclassifications
Total comprehensive loss
Net loss per share:
Net loss per share, basic (in dollars per share)
Net loss per share, diluted (in dollars per share)
Weighted-average common shares outstanding:
Weighted-average common shares outstanding, basic (in shares)
Weighted-average common shares outstanding, diluted (in shares)

Comments